Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
252.64
0.00 (0.00%)
May 12, 2025, 4:00 PM - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $6.87 billion as of May 12, 2025. Its market cap has decreased by -13.01% in one year.
Market Cap
6.87B
Enterprise Value
6.58B
1-Year Change
-13.01%
Ranking
Category
Stock Price
$252.64
Market Cap Chart
Since May 13, 2020, Bio-Rad Laboratories's market cap has decreased from $13.49B to $6.87B, a decrease of -49.06%. That is a compound annual growth rate of -12.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 6.67B | -27.49% |
| Dec 31, 2024 | 9.20B | -1.07% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 28.86% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |